Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Phase 1b, Randomized, Double-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated:  10/8/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Phase 1b, Randomized, Double-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated: 10/8/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Phase 1b, Randomized, Double-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated:  10/8/2015
Clinical Research Facility
mi
from
Knoxville, TN
Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Phase 1b, Randomized, Double-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated: 10/8/2015
Clinical Research Facility
mi
from
Knoxville, TN
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Phase 1b, Randomized, Double-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated:  10/8/2015
Clinical Research Facility
mi
from
San Antonio, TX
Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Phase 1b, Randomized, Double-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated: 10/8/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Phase 1b, Randomized, Double-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated:  10/8/2015
Research site
mi
from
San Juan,
Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Phase 1b, Randomized, Double-Blind, Multiple-Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GS-9857 in Subjects With Chronic Hepatitis C Virus Infection
Status: Enrolling
Updated: 10/8/2015
Research site
mi
from
San Juan,
Click here to add this to my saved trials
Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma
Phase II Study of MK-2206 in Patients With Relapsed Lymphoma
Status: Enrolling
Updated:  10/9/2015
M D Anderson Cancer Center
mi
from
Houston, TX
Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma
Phase II Study of MK-2206 in Patients With Relapsed Lymphoma
Status: Enrolling
Updated: 10/9/2015
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-III)
Status: Enrolling
Updated:  10/9/2015
Clinical Research Facility
mi
from
Manhasset, NY
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-III)
Status: Enrolling
Updated: 10/9/2015
Clinical Research Facility
mi
from
Manhasset, NY
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-III)
Status: Enrolling
Updated:  10/9/2015
Clinical Research Facility
mi
from
Jacksonville, FL
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-III)
Status: Enrolling
Updated: 10/9/2015
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-III)
Status: Enrolling
Updated:  10/9/2015
Clinical Research Facility
mi
from
Aurora, CO
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-III)
Status: Enrolling
Updated: 10/9/2015
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-III)
Status: Enrolling
Updated:  10/9/2015
Clinical Research Facility
mi
from
Seattle, WA
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-III)
Status: Enrolling
Updated: 10/9/2015
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-III)
Status: Enrolling
Updated:  10/9/2015
Clinical Research Facility
mi
from
Gainesville, FL
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-III)
Status: Enrolling
Updated: 10/9/2015
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-III)
Status: Enrolling
Updated:  10/9/2015
Clinical Research Facility
mi
from
San Antonio, TX
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-III)
Status: Enrolling
Updated: 10/9/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-III)
Status: Enrolling
Updated:  10/9/2015
Clinical Research Facility
mi
from
Catonsville, MD
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-III)
Status: Enrolling
Updated: 10/9/2015
Clinical Research Facility
mi
from
Catonsville, MD
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-III)
Status: Enrolling
Updated:  10/9/2015
Clinical Research Facility
mi
from
Statesville, NC
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-III)
Status: Enrolling
Updated: 10/9/2015
Clinical Research Facility
mi
from
Statesville, NC
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-III)
Status: Enrolling
Updated:  10/9/2015
Clinical Research Facility
mi
from
Phoenix, AZ
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-III)
Status: Enrolling
Updated: 10/9/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-III)
Status: Enrolling
Updated:  10/9/2015
Clinical Research Facility
mi
from
Germantown, TN
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-III)
Status: Enrolling
Updated: 10/9/2015
Clinical Research Facility
mi
from
Germantown, TN
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-III)
Status: Enrolling
Updated:  10/9/2015
Site: 3202
mi
from
Antwerp,
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
An Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (TURQUOISE-III)
Status: Enrolling
Updated: 10/9/2015
Site: 3202
mi
from
Antwerp,
Click here to add this to my saved trials
Meditation and Exercise for Prevention of Acute Respiratory Infection
Meditation and Exercise for Prevention of Acute Respiratory Infection
Status: Enrolling
Updated:  10/9/2015
University of Wisconsin
mi
from
Madison, WI
Meditation and Exercise for Prevention of Acute Respiratory Infection
Meditation and Exercise for Prevention of Acute Respiratory Infection
Status: Enrolling
Updated: 10/9/2015
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients
Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients With Possible Bacterial Infection
Status: Enrolling
Updated:  10/12/2015
Sparrow Hospital
mi
from
Lansing, MI
Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients
Pharmacokinetic/Pharmacodynamic Study of Doripenem in Febrile Neutropenic Patients With Possible Bacterial Infection
Status: Enrolling
Updated: 10/12/2015
Sparrow Hospital
mi
from
Lansing, MI
Click here to add this to my saved trials
Evaluating the Pharmacokinetics of High-Dose Rifapentine When Given as a Single Dose or in Divided Doses to Healthy Adults
Phase I Clinical Trial of the Pharmacokinetics of High-dose Daily Rifapentine, Given as a Single Dose or in Divided Doses to Healthy Volunteers
Status: Enrolling
Updated:  10/13/2015
UCSD Antiviral Research Center CRS
mi
from
San Diego, CA
Evaluating the Pharmacokinetics of High-Dose Rifapentine When Given as a Single Dose or in Divided Doses to Healthy Adults
Phase I Clinical Trial of the Pharmacokinetics of High-dose Daily Rifapentine, Given as a Single Dose or in Divided Doses to Healthy Volunteers
Status: Enrolling
Updated: 10/13/2015
UCSD Antiviral Research Center CRS
mi
from
San Diego, CA
Click here to add this to my saved trials
Evaluating the Pharmacokinetics of High-Dose Rifapentine When Given as a Single Dose or in Divided Doses to Healthy Adults
Phase I Clinical Trial of the Pharmacokinetics of High-dose Daily Rifapentine, Given as a Single Dose or in Divided Doses to Healthy Volunteers
Status: Enrolling
Updated:  10/13/2015
Johns Hopkins University CRS
mi
from
Baltimore, MD
Evaluating the Pharmacokinetics of High-Dose Rifapentine When Given as a Single Dose or in Divided Doses to Healthy Adults
Phase I Clinical Trial of the Pharmacokinetics of High-dose Daily Rifapentine, Given as a Single Dose or in Divided Doses to Healthy Volunteers
Status: Enrolling
Updated: 10/13/2015
Johns Hopkins University CRS
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluating the Pharmacokinetics of High-Dose Rifapentine When Given as a Single Dose or in Divided Doses to Healthy Adults
Phase I Clinical Trial of the Pharmacokinetics of High-dose Daily Rifapentine, Given as a Single Dose or in Divided Doses to Healthy Volunteers
Status: Enrolling
Updated:  10/13/2015
Chapel Hill CRS
mi
from
Chapel Hill, NC
Evaluating the Pharmacokinetics of High-Dose Rifapentine When Given as a Single Dose or in Divided Doses to Healthy Adults
Phase I Clinical Trial of the Pharmacokinetics of High-dose Daily Rifapentine, Given as a Single Dose or in Divided Doses to Healthy Volunteers
Status: Enrolling
Updated: 10/13/2015
Chapel Hill CRS
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Evaluating the Pharmacokinetics of High-Dose Rifapentine When Given as a Single Dose or in Divided Doses to Healthy Adults
Phase I Clinical Trial of the Pharmacokinetics of High-dose Daily Rifapentine, Given as a Single Dose or in Divided Doses to Healthy Volunteers
Status: Enrolling
Updated:  10/13/2015
Vanderbilt Therapeutics (VT) CRS
mi
from
Nashville, TN
Evaluating the Pharmacokinetics of High-Dose Rifapentine When Given as a Single Dose or in Divided Doses to Healthy Adults
Phase I Clinical Trial of the Pharmacokinetics of High-dose Daily Rifapentine, Given as a Single Dose or in Divided Doses to Healthy Volunteers
Status: Enrolling
Updated: 10/13/2015
Vanderbilt Therapeutics (VT) CRS
mi
from
Nashville, TN
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
MBCCOP - Gulf Coast
mi
from
Mobile, AL
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
MBCCOP - Gulf Coast
mi
from
Mobile, AL
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Mobile Infirmary Medical Center
mi
from
Mobile, AL
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Mobile Infirmary Medical Center
mi
from
Mobile, AL
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Cedar Rapids Oncology Associates
mi
from
Cedar Rapids, IA
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Cedar Rapids Oncology Associates
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
McCreery Cancer Center at Ottumwa Regional
mi
from
Ottumwa, IA
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
McCreery Cancer Center at Ottumwa Regional
mi
from
Ottumwa, IA
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Siouxland Hematology-Oncology Associates, LLP
mi
from
Sioux City, IA
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Siouxland Hematology-Oncology Associates, LLP
mi
from
Sioux City, IA
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Mercy Medical Center - Sioux City
mi
from
Sioux City, IA
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Mercy Medical Center - Sioux City
mi
from
Sioux City, IA
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
St. Luke's Regional Medical Center
mi
from
Sioux City, IA
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
St. Luke's Regional Medical Center
mi
from
Sioux City, IA
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
CCOP - Wichita
mi
from
Wichita, KA
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Green Bay Oncology, Limited - Escanaba
mi
from
Escanaba, MI
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Green Bay Oncology, Limited - Escanaba
mi
from
Escanaba, MI
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Dickinson County Healthcare System
mi
from
Iron Mountain, MI
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Dickinson County Healthcare System
mi
from
Iron Mountain, MI
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
CCOP - Kalamazoo
mi
from
Kalamazoo, MI
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
CCOP - Kalamazoo
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
CCOP - Metro-Minnesota
mi
from
St. Louis Park, MN
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
CCOP - Metro-Minnesota
mi
from
St. Louis Park, MN
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
CCOP - Kansas City
mi
from
Kansas City, MO
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
CCOP - Kansas City
mi
from
Kansas City, MO
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Hunterdon Regional Cancer Center at Hunterdon Medical Center
mi
from
Flemington, NJ
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Hunterdon Regional Cancer Center at Hunterdon Medical Center
mi
from
Flemington, NJ
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Warren Hospital
mi
from
Phillipsburg, NJ
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Warren Hospital
mi
from
Phillipsburg, NJ
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Our Lady of Mercy Medical Center Comprehensive Cancer Center
mi
from
Bronx, NY
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Our Lady of Mercy Medical Center Comprehensive Cancer Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
CCOP - Hematology-Oncology Associates of Central New York
mi
from
East Syracuse, NY
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
CCOP - Hematology-Oncology Associates of Central New York
mi
from
East Syracuse, NY
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
St. Vincent's Comprehensive Cancer Center - Manhattan
mi
from
New York, NY
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
St. Vincent's Comprehensive Cancer Center - Manhattan
mi
from
New York, NY
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
CCOP - Southeast Cancer Control Consortium
mi
from
Goldsboro, NC
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
CCOP - Southeast Cancer Control Consortium
mi
from
Goldsboro, NC
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Mercy Cancer Center at Mercy Medical Center
mi
from
Canton, OH
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Mercy Cancer Center at Mercy Medical Center
mi
from
Canton, OH
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
MetroHealth Cancer Care Center at MetroHealth Medical Center
mi
from
Cleveland, OH
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
MetroHealth Cancer Care Center at MetroHealth Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
CCOP - Columbus
mi
from
Columbus, OH
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
CCOP - Columbus
mi
from
Columbus, OH
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
CCOP - Dayton
mi
from
Dayton, OH
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
CCOP - Dayton
mi
from
Dayton, OH
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
CCOP - Columbia River Oncology Program
mi
from
Portland, OR
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
CCOP - Columbia River Oncology Program
mi
from
Portland, OR
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Penn State Cancer Institute at Milton S. Hershey Medical Center
mi
from
Hershey, PA
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Penn State Cancer Institute at Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated:  10/13/2015
Lewistown Hospital
mi
from
Lewistown, PA
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Oral Antibiotic Prophylaxis of Early Infection in Multiple Myeloma
Status: Enrolling
Updated: 10/13/2015
Lewistown Hospital
mi
from
Lewistown, PA
Click here to add this to my saved trials